In line with the Trump administration’s goal to curb the U.S.’ reliance on overseas drug manufacturing, the FDA has deployed a new program designed to take some of the headache out of setting up ...
Amid an outpouring of industry investments in U.S. drug production, the FDA has launched a new program designed to significantly reduce the complexities involved in setting up domestic manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results